U.S. AI Driven Diabetic Retinopathy Screening Market Estimations (2025 - 2035)
The U.S. AI driven diabetic retinopathy screening market covers artificial intelligence systems and related cameras and services used to screen people with diabetes for diabetic retinopathy in the United States, including AI software billed per exam, tabletop and handheld retinal cameras and implementation and support services, using autonomous and assistive AI, in primary care, endocrinology and diabetes clinics, retail and pharmacy clinics, eye care practices and other settings.